Oxford University Innovation announces the much-anticipated relaunch of the Oxford Innovation Society (OIS). With an ambitious 12-month programme of events, OIS aims to fortify connections between Oxford’s companies, investors, industry partners and the vibrant Oxford entrepreneurial ecosystem.
OUI’s Diabetes Health Profiles empower those living with diabetes to have a voice in their healthcare.
Available to licence through Oxford University Innovation’s Clinical Outcomes team.
Now available to licence through Oxford University Innovation’s Clinical Outcomes team.
Oxford University Innovation's Clinical Outcome team will be attending and presenting at the annual ISOQOL 2023 conference in Calgary, Canada from the 18th - 21st October 2023.
The GCA-PRO is a validated outcome measure for use in clinical trials, observation studies and clinical practice. It can also be used as a communication tool between patients and their clinicians, to highlight areas of greatest importance to patients, within face to face or online consultations.
Dr Liisa Chisty joins Oxford University Innovation's Clinical Outcomes Team, reinforcing their commitment to patient-centric care and licensing Clinical Outcome Assessments (COAs).
Less than two weeks to go! The 7th UK Patient Reported Outcome Measures (PROMs) Research Conference, hosted by our colleagues at the School of Health and Related Research, University of Sheffield, will be taking place Thursday 22nd June 2023.
Evaluating response rates, data quality, score reliability and scaling assumptions of the Oxford Participation and Activities Questionnaire (Ox-PAQ) within Sweden.
